Company Filing History:
Years Active: 2017-2019
Title: Innovations by Pedro Brugarolas
Introduction
Pedro Brugarolas is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of therapeutics and medical imaging, holding a total of 3 patents. His work focuses on novel compounds that have the potential to improve the diagnosis and treatment of various medical conditions.
Latest Patents
One of his latest patents involves the use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging. This patent provides novel compounds that bind to potassium channels, along with methods for their manufacture and use. These compounds can be utilized to diagnose and assess traumatic brain injury, treat demyelinating diseases, and conduct in vivo imaging of the central nervous system. Additionally, they can help diagnose and assess the progression of multiple sclerosis and other diseases. Another patent disclosed methods for the fluorination of aromatic N-heterocyclic N-oxides, which may be reduced to fluorinated aromatic N-heterocyclic amine analogs. This innovative fluorination approach can be effectively applied to synthesize aromatic N-heterocyclic compounds labeled with fluorine.
Career Highlights
Pedro Brugarolas is affiliated with the University of Chicago, where he continues to advance his research and innovation in the medical field. His work has garnered attention for its potential impact on therapeutic practices and medical diagnostics.
Collaborations
He collaborates with notable colleagues such as Brian Popko and Daniel Appelbaum, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Pedro Brugarolas exemplifies the spirit of innovation in the medical field through his patents and research at the University of Chicago. His contributions are paving the way for advancements in therapeutics and medical imaging.